Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices

The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanism...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 14; p. 1127388
Main Authors Wu, Qin, Ross, Abigail J., Ipek, Tugce, Thompson, Georgina H., Johnson, Robert D., Wu, Changhao, Camelliti, Patrizia
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 05.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
AbstractList The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
Author Wu, Qin
Johnson, Robert D.
Camelliti, Patrizia
Thompson, Georgina H.
Ross, Abigail J.
Ipek, Tugce
Wu, Changhao
AuthorAffiliation 1 School of Medicine , Jiangsu Vocational College of Medicine , Yancheng , China
2 School of Biosciences and Medicine , University of Surrey , Guildford , United Kingdom
AuthorAffiliation_xml – name: 2 School of Biosciences and Medicine , University of Surrey , Guildford , United Kingdom
– name: 1 School of Medicine , Jiangsu Vocational College of Medicine , Yancheng , China
Author_xml – sequence: 1
  givenname: Qin
  surname: Wu
  fullname: Wu, Qin
– sequence: 2
  givenname: Abigail J.
  surname: Ross
  fullname: Ross, Abigail J.
– sequence: 3
  givenname: Tugce
  surname: Ipek
  fullname: Ipek, Tugce
– sequence: 4
  givenname: Georgina H.
  surname: Thompson
  fullname: Thompson, Georgina H.
– sequence: 5
  givenname: Robert D.
  surname: Johnson
  fullname: Johnson, Robert D.
– sequence: 6
  givenname: Changhao
  surname: Wu
  fullname: Wu, Changhao
– sequence: 7
  givenname: Patrizia
  surname: Camelliti
  fullname: Camelliti, Patrizia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37214466$$D View this record in MEDLINE/PubMed
BookMark eNp9Uktv1DAQtlARfdA_wAHlyGUXPxLHPiFUAa1UiUtPXKyJM9m48saL7a3Y_nqc3W3VcsAXW_b38Mx85-RkChMS8oHRpRBKfx42I8Qlp1wsGeOtUOoNOWNSioVWjJ-8OJ-Sy5TuaVlCayHrd-RUtJzVtZRn5Nf1ro_hz86OPsTwe-smrGDqK3h0eYxhvbNuqsBnjFUesbJhyhFsdt7lXRWGyrsHN62qTYh2po4IMVfJO4vpPXk7gE94edwvyN33b3dX14vbnz9urr7eLmwtdV4MIBl2HDsLLQfW9qUWizWzvRW0k41kgwDVWy2x6bmgOHRcN2gBlcaGiQtyc5DtA9ybTXRriDsTwJn9RYgrU_7krEfTyR5KC2pQqq6LVadlXXQ0Q9q1FHXR-nLQ2my7NfYW52r9K9HXL5MbzSo8GEaZlqJRReHTUWHuJqZs1i5Z9B4mDNtkuGKKNi1tmwL9-NLs2eVpOAXADwAbQ0oRh2cIo2YOgdmHwMwhMMcQFJL6h2Rdhuz2g3P-f9S_BBC7gw
CitedBy_id crossref_primary_10_3389_fcvm_2023_1244630
Cites_doi 10.1089/ten.tec.2022.0053
10.1161/CIRCRESAHA.117.310230
10.1007/s12012-014-9289-4
10.1016/j.isci.2021.103509
10.1093/eurheartj/ehz779
10.1038/s41591-020-0888-2
10.1016/j.ajem.2019.158387
10.1038/s41422-020-0282-0
10.1093/cid/ciaa691
10.3390/antibiotics8030110
10.1159/000257528
10.1093/toxsci/kfaa194
10.5483/BMBRep.2020.53.10.165
10.1016/0014-2999(81)90458-1
10.1007/s10557-018-06847-9
10.3389/fphys.2022.839140
10.1016/j.yjmcc.2020.12.014
10.1016/s1043661802002384
10.1111/bph.15101
10.3390/ph15020220
10.1016/j.xcrm.2021.100216
10.1161/CIRCEP.115.003560
10.2217/fca.09.32
10.3389/fphys.2019.00755
10.1007/BF00261499
10.1111/j.1476-5381.2011.01775.x
10.1111/cts.13011
10.1183/09031936.00095809
10.1016/S1473-3099(07)70187-1
10.1056/NEJMoa2019014
10.1016/0014-2999(90)90108-i
10.1113/JP276239
10.14814/phy2.12413
10.1001/jamacardio.2020.1834
10.1038/srep28798
10.1016/j.yjmcc.2011.06.018
10.1016/j.hrthm.2020.05.030
10.1016/j.hrthm.2015.05.027
10.1016/j.taap.2020.115213
10.1161/CIRCEP.120.008662
10.3389/fphar.2021.684252
10.1007/s12012-017-9401-7
10.1021/acsptsci.1c00166
ContentType Journal Article
Copyright Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti.
Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti
Copyright_xml – notice: Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti.
– notice: Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2023.1127388
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Wu et al
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_b6da9934a8844a17b964cae91e0b70e9
PMC10196358
37214466
10_3389_fphar_2023_1127388
Genre Journal Article
GrantInformation_xml – fundername: British Heart Foundation
  grantid: PG/22/11172
– fundername: NIA NIH HHS
  grantid: R01 AG049321
– fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-fa61eb2ebca72a17d738ce41cdc30b6561f3a8dc96e5d230efb295ecae89e513
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:32:17 EDT 2025
Thu Aug 21 18:37:00 EDT 2025
Fri Jul 11 12:04:23 EDT 2025
Sat May 31 02:13:32 EDT 2025
Tue Jul 01 02:53:05 EDT 2025
Thu Apr 24 22:51:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
cardiotoxicity
calcium channels
myocardial slices
safety pharmacology
Bay K8644
organotypic ex-vivo models
Language English
License Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-fa61eb2ebca72a17d738ce41cdc30b6561f3a8dc96e5d230efb295ecae89e513
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Daniel M. Johnson, The Open University, United Kingdom
Edited by: Jose R. Lopez, Mount Sinai Medical Center, United States
Tamer M. A. Mohamed, University of Louisville, United States
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2023.1127388
PMID 37214466
PQID 2818057075
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b6da9934a8844a17b964cae91e0b70e9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10196358
proquest_miscellaneous_2818057075
pubmed_primary_37214466
crossref_primary_10_3389_fphar_2023_1127388
crossref_citationtrail_10_3389_fphar_2023_1127388
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-05-05
PublicationDateYYYYMMDD 2023-05-05
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-05
  day: 05
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References White (B42) 2007; 7
He (B16) 2019; 10
Saleh (B34) 2020; 13
Chorin (B8) 2020; 26
Tona (B37) 1990; 178
Zhang (B45) 2017; 17
Di Paolo (B12) 2002; 46
Ippolito (B20) 2020; 71
Kang (B23) 2016; 6
Li (B26) 2022; 15
Sanchez-Chapula (B35) 2001; 297
Uzelac (B38) 2020; 17
Wen (B41) 2018; 596
Wong (B43) 2021; 153
Eisner (B13) 2017; 121
Galan (B14) 2017; 23
Wang (B40) 2020; 30
Jiang (B21) 2019; 8
Kim (B25) 2020; 53
Miller (B29) 2020; 406
Himmel (B17) 2012; 166
Perbellini (B32) 2020; 41
Segal (B36) 2022; 13
Yang (B44) 2017; 10
Camelliti (B3) 2011; 51
Chaanine (B6) 2015; 3
Kim (B24) 2021; 24
Ikhinmwin (B19) 1981; 69
Blignaut (B1) 2019; 33
Hughes (B18) 2020; 177
Mamoshina (B27) 2021; 2
Ohara (B31) 2015; 15
Cavalcanti (B5) 2020; 383
Wang (B39) 2021; 4
Riou (B33) 1989; 15
de Boer (B9) 2009; 5
Gielen (B15) 2010; 36
Capel (B4) 2015; 12
Mercuro (B28) 2020; 5
Bussek (B2) 2009; 24
Charrez (B7) 2021; 12
Oguntuyo (B30) 2022; 28
de Olano (B10) 2019; 37
Jordaan (B22) 2021; 180
Delaunois (B11) 2021; 14
References_xml – volume: 28
  start-page: 457
  year: 2022
  ident: B30
  article-title: Robust, automated analysis of electrophysiology in induced pluripotent stem cell-derived micro-heart muscle for drug toxicity
  publication-title: Tissue Eng. Part C Methods
  doi: 10.1089/ten.tec.2022.0053
– volume: 121
  start-page: 181
  year: 2017
  ident: B13
  article-title: Calcium and excitation-contraction coupling in the heart
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.117.310230
– volume: 15
  start-page: 232
  year: 2015
  ident: B31
  article-title: Azithromycin can prolong QT interval and suppress ventricular contraction, but will not induce torsade de Pointes
  publication-title: Cardiovasc Toxicol.
  doi: 10.1007/s12012-014-9289-4
– volume: 24
  start-page: 103509
  year: 2021
  ident: B24
  article-title: Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells
  publication-title: iScience
  doi: 10.1016/j.isci.2021.103509
– volume: 41
  start-page: 2405
  year: 2020
  ident: B32
  article-title: Living myocardial slices: A novel multicellular model for cardiac translational research
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehz779
– volume: 26
  start-page: 808
  year: 2020
  ident: B8
  article-title: The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0888-2
– volume: 37
  start-page: e5
  year: 2019
  ident: B10
  article-title: Toxicokinetics of hydroxychloroquine following a massive overdose
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2019.158387
– volume: 30
  start-page: 269
  year: 2020
  ident: B40
  article-title: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
  publication-title: Cell Res.
  doi: 10.1038/s41422-020-0282-0
– volume: 71
  start-page: 2965
  year: 2020
  ident: B20
  article-title: Dose optimization of hydroxychloroquine for coronavirus infection 2019: Do blood concentrations matter?
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa691
– volume: 8
  start-page: 110
  year: 2019
  ident: B21
  article-title: Mitochondrial toxicity of azithromycin results in aerobic glycolysis and DNA damage of human mammary epithelia and fibroblasts
  publication-title: Antibiot. (Basel)
  doi: 10.3390/antibiotics8030110
– volume: 24
  start-page: 527
  year: 2009
  ident: B2
  article-title: Tissue slices from adult mammalian hearts as a model for pharmacological drug testing
  publication-title: Cell Physiol. Biochem.
  doi: 10.1159/000257528
– volume: 180
  start-page: 356
  year: 2021
  ident: B22
  article-title: Cardiotoxic potential of hydroxychloroquine, chloroquine and azithromycin in adult human primary cardiomyocytes
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfaa194
– volume: 53
  start-page: 545
  year: 2020
  ident: B25
  article-title: Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes
  publication-title: BMB Rep.
  doi: 10.5483/BMBRep.2020.53.10.165
– volume: 69
  start-page: 507
  year: 1981
  ident: B19
  article-title: The effects of calcium ions on the depression of cardiac contractility by chloroquine and quinine
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/0014-2999(81)90458-1
– volume: 33
  start-page: 1
  year: 2019
  ident: B1
  article-title: Revisiting the cardiotoxic effect of chloroquine
  publication-title: Cardiovasc Drugs Ther.
  doi: 10.1007/s10557-018-06847-9
– volume: 13
  start-page: 839140
  year: 2022
  ident: B36
  article-title: Increase in Ca(2+)-activated cAMP/PKA signaling prevents hydroxychloroquine-induced bradycardia of the cardiac pacemaker
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2022.839140
– volume: 153
  start-page: 106
  year: 2021
  ident: B43
  article-title: Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
  publication-title: J. Mol. Cell Cardiol.
  doi: 10.1016/j.yjmcc.2020.12.014
– volume: 46
  start-page: 545
  year: 2002
  ident: B12
  article-title: Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily
  publication-title: Pharmacol. Res.
  doi: 10.1016/s1043661802002384
– volume: 177
  start-page: 4975
  year: 2020
  ident: B18
  article-title: Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.15101
– volume: 15
  start-page: 220
  year: 2022
  ident: B26
  article-title: Synergistic adverse effects of azithromycin and hydroxychloroquine on human cardiomyocytes at a clinically relevant treatment duration
  publication-title: Pharm. (Basel)
  doi: 10.3390/ph15020220
– volume: 297
  start-page: 437
  year: 2001
  ident: B35
  article-title: Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 2
  start-page: 100216
  year: 2021
  ident: B27
  article-title: Toward a broader view of mechanisms of drug cardiotoxicity
  publication-title: Cell Rep. Med.
  doi: 10.1016/j.xcrm.2021.100216
– volume: 10
  start-page: e003560
  year: 2017
  ident: B44
  article-title: Azithromycin causes a novel proarrhythmic syndrome
  publication-title: Circ. Arrhythm. Electrophysiol.
  doi: 10.1161/CIRCEP.115.003560
– volume: 5
  start-page: 425
  year: 2009
  ident: B9
  article-title: Myocardial tissue slices: Organotypic pseudo-2D models for cardiac research & development
  publication-title: Future Cardiol.
  doi: 10.2217/fca.09.32
– volume: 23
  year: 2017
  ident: B14
  article-title: Negative inotropic action and QT prolongation by azithromycin
  publication-title: Rev. Cuba. Cardiol. Cir. Cardiovasc.
– volume: 10
  start-page: 755
  year: 2019
  ident: B16
  article-title: A protocol for transverse cardiac slicing and optical mapping in murine heart
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2019.00755
– volume: 15
  start-page: 390
  year: 1989
  ident: B33
  article-title: Diazepam does not improve the mechanical performance of rat cardiac papillary muscle exposed to chloroquine in vitro
  publication-title: Intensive Care Med.
  doi: 10.1007/BF00261499
– volume: 166
  start-page: 276
  year: 2012
  ident: B17
  article-title: Field and action potential recordings in heart slices: Correlation with established in vitro and in vivo models
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2011.01775.x
– volume: 14
  start-page: 1133
  year: 2021
  ident: B11
  article-title: Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19
  publication-title: Clin. Transl. Sci.
  doi: 10.1111/cts.13011
– volume: 36
  start-page: 646
  year: 2010
  ident: B15
  article-title: Azithromycin induces anti-viral responses in bronchial epithelial cells
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.00095809
– volume: 7
  start-page: 549
  year: 2007
  ident: B42
  article-title: Cardiotoxicity of antimalarial drugs
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(07)70187-1
– volume: 383
  start-page: 2041
  year: 2020
  ident: B5
  article-title: Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2019014
– volume: 178
  start-page: 293
  year: 1990
  ident: B37
  article-title: Depressant effects of chloroquine on the isolated Guinea-pig heart
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/0014-2999(90)90108-i
– volume: 596
  start-page: 3951
  year: 2018
  ident: B41
  article-title: Transverse cardiac slicing and optical imaging for analysis of transmural gradients in membrane potential and Ca(2+) transients in murine heart
  publication-title: J. Physiol.
  doi: 10.1113/JP276239
– volume: 3
  start-page: e12413
  year: 2015
  ident: B6
  article-title: High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy
  publication-title: Physiol. Rep.
  doi: 10.14814/phy2.12413
– volume: 5
  start-page: 1036
  year: 2020
  ident: B28
  article-title: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)
  publication-title: JAMA Cardiol.
  doi: 10.1001/jamacardio.2020.1834
– volume: 6
  start-page: 28798
  year: 2016
  ident: B23
  article-title: Human organotypic cultured cardiac slices: New platform for high throughput preclinical human trials
  publication-title: Sci. Rep.
  doi: 10.1038/srep28798
– volume: 51
  start-page: 390
  year: 2011
  ident: B3
  article-title: Adult human heart slices are a multicellular system suitable for electrophysiological and pharmacological studies
  publication-title: J. Mol. Cell Cardiol.
  doi: 10.1016/j.yjmcc.2011.06.018
– volume: 17
  start-page: 1445
  year: 2020
  ident: B38
  article-title: Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19
  publication-title: Heart rhythm.
  doi: 10.1016/j.hrthm.2020.05.030
– volume: 12
  start-page: 2186
  year: 2015
  ident: B4
  article-title: Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential
  publication-title: Heart rhythm.
  doi: 10.1016/j.hrthm.2015.05.027
– volume: 406
  start-page: 115213
  year: 2020
  ident: B29
  article-title: Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2020.115213
– volume: 13
  start-page: e008662
  year: 2020
  ident: B34
  article-title: Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection
  publication-title: Circ. Arrhythm. Electrophysiol.
  doi: 10.1161/CIRCEP.120.008662
– volume: 12
  start-page: 684252
  year: 2021
  ident: B7
  article-title: Heart muscle microphysiological system for cardiac liability prediction of repurposed COVID-19 therapeutics
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.684252
– volume: 17
  start-page: 434
  year: 2017
  ident: B45
  article-title: Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin
  publication-title: Cardiovasc Toxicol.
  doi: 10.1007/s12012-017-9401-7
– volume: 4
  start-page: 1639
  year: 2021
  ident: B39
  article-title: Electrophysiological and proarrhythmic effects of hydroxychloroquine challenge in Guinea-pig hearts
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.1c00166
SSID ssj0000399364
Score 2.3193207
Snippet The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1127388
SubjectTerms calcium channels
cardiotoxicity
COVID-19
myocardial slices
organotypic ex-vivo models
Pharmacology
safety pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYv4tr6IIHvR4qZJ0_aooiyC4mEF8RLyKrug3UXXw_rrnUm7LxG9eO2Dhplp5_uamW8IOZGFTTgwthgTQiwM97FuGxa7xPnSccONRaJ4dy87j-L2KX2aG_WFNWG1PHBtuHMjnYYcKnSeC6FZZgoprPYF822TtX1o3YOcN0emwjcY864UdZcMsLDivBz2NOp_Jhy7ZjIeRq3MMlEQ7P8JZX4vlpzLPjdrZLWBjfSiXu46WfLVBmk91LrT4zPanbVRvZ_RFn2YKVKPN8lzZ-ywXMX2gJ3DkwFZUl05qj_7OCbhdWz7FQ375hTwIA3l69jwgBCdDkr60sffDhSgOm7DUxyCPaIAUOEbs0W6N9fdq07cDFWILTDhUVxqycA3WAOVJWBPB6awXjDrLG8bQHes5Dp3tpA-dcBPfGmSIvVg8rzwKePbZLkaVH6X0EQDXNBG6Exq4fO0KNNEll5Kxy2QOBMRNrGvso3gOM69eFFAPNAnKvhEoU9U45OInE7vGdZyG79efYlum16JUtnhAASQagJI_RVAETmeOF3Bq4X7Jbryg493hUJZAGcBVEVkpw6C6aN4FrTmZETyhfBYWMvimarfC_LdDCWJeJrv_cfq98kKWiSUYKYHZHn09uEPASaNzFF4I74AtOAVHw
  priority: 102
  providerName: Directory of Open Access Journals
Title Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
URI https://www.ncbi.nlm.nih.gov/pubmed/37214466
https://www.proquest.com/docview/2818057075
https://pubmed.ncbi.nlm.nih.gov/PMC10196358
https://doaj.org/article/b6da9934a8844a17b964cae91e0b70e9
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcuGCeBP6kJFQLzSwjh3HOVQIENUKqaiHrVRxifxKd6UlW3a3UtNfz4yT3bKocOCa2EoyY3u-Lx5_A_BGlS4TyNhSCgiptCKkZmB56jMfai-ssI6I4sk3NTyTX8_z8y1YlTvqDbi4k9pRPamz-fTd9c_2A074I2KcGG_f15djQ9KemaADMYXQ-h7cx8hUUEWDkx7ux5WZorGS3dmZv3TdiE9Rxv8u7PlnCuVvMen4ETzswST72Hn_MWyF5gkcnHZq1O0hG90erlocsgN2eqtT3T6F78PWUxKLGyNnxycj3mSm8czcTKh4wo_WTRoWd9MZokQWk9rpGAQBdzar2XRCPyMY2o425xmVxl4yhK248jyD0fGX0edh2pdaSB3y42VaG8XRY5QZVWSGFx5N4YLkzjsxsIj5eC2M9q5UIffIWkJtszIPzgRdhpyL57DdzJrwElhmEEQYK02hjAw6L-s8U3VQyguH1M4mwFf2rVwvQ07VMKYV0hHySRV9UpFPqt4nCbxd97nsRDj-2foTuW3dkgS044XZ_KLq52NllTc4GKTRWkr8YFsqiV9T8jCwxSCUCbxeOb3CCUe7KKYJs6tFRfJZCHIRaiXwohsE60eJIirQqQT0xvDYeJfNO81kHEW9OQkViVy_-v-uO_CA7BDTMfNd2F7Or8IeQqal3Y-_GvbjbPgFz34dRw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hydroxychloroquine+and+azithromycin+alter+the+contractility+of+living+porcine+heart+slices&rft.jtitle=Frontiers+in+pharmacology&rft.au=Wu%2C+Qin&rft.au=Ross%2C+Abigail+J.&rft.au=Ipek%2C+Tugce&rft.au=Thompson%2C+Georgina+H.&rft.date=2023-05-05&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=14&rft_id=info:doi/10.3389%2Ffphar.2023.1127388&rft.externalDocID=PMC10196358
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon